Sowing the seeds of knowledge in brachytherapy

Claire Deering: why it is our duty to ensure we do all that we can to understand brachytherapy for better patient care.

Oncology clinical nurse specialists (CNSs) are at the heart of multidisciplinary teams (MDTs). They make an invaluable contribution to supporting patients across the whole care pathway.

It is essential that nurses are able to communicate in-depth knowledge about a person's disease and all the treatment options available to them.

In the case of prostate CNSs, this leads to an interesting conundrum: a high number of prostate CNSs do not yet have access to the full range of services, available which presents limitations in their understanding of them, however it is our clinical duty to be able to give patients informed and impartial answers. One treatment where access and knowledge can be limited is brachytherapy – a form of internal radiotherapy that directly targets the affected area and is sometimes called implant therapy or seed implantation.

The clinical duty


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?